232 related articles for article (PubMed ID: 2571477)
1. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.
Williams DE; Reed RL; Kedzierski B; Dannan GA; Guengerich FP; Buhler DR
Drug Metab Dispos; 1989; 17(4):387-92. PubMed ID: 2571477
[TBL] [Abstract][Full Text] [Related]
2. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
Chung WG; Buhler DR
Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
[TBL] [Abstract][Full Text] [Related]
3. The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters.
Huan JY; Miranda CL; Buhler DR; Cheeke PR
Toxicol Appl Pharmacol; 1998 Aug; 151(2):229-35. PubMed ID: 9707499
[TBL] [Abstract][Full Text] [Related]
4. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
Wang YP; Yan J; Fu PP; Chou MW
Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
[TBL] [Abstract][Full Text] [Related]
5. Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver.
Miranda CL; Reed RL; Guengerich FP; Buhler DR
Carcinogenesis; 1991 Mar; 12(3):515-9. PubMed ID: 2009596
[TBL] [Abstract][Full Text] [Related]
6. The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine.
Williams DE; Reed RL; Kedzierski B; Ziegler DM; Buhler DR
Drug Metab Dispos; 1989; 17(4):380-6. PubMed ID: 2571476
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
Yan J; Xia Q; Chou MW; Fu PP
Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
[TBL] [Abstract][Full Text] [Related]
8. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
Xia Q; Yan J; Chou MW; Fu PP
Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P-450 isozymes in metabolic activation of delta 9-tetrahydrocannabinol by rat liver microsomes.
Narimatsu S; Watanabe K; Matsunaga T; Yamamoto I; Imaoka S; Funae Y; Yoshimura H
Drug Metab Dispos; 1990; 18(6):943-8. PubMed ID: 1981541
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
Wang YP; Fu PP; Chou MW
Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
12. Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
Chung WG; Buhler DR
Drug Metab Dispos; 1995 Nov; 23(11):1263-7. PubMed ID: 8591728
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
Wang YP; Yan J; Beger RD; Fu PP; Chou MW
Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
[TBL] [Abstract][Full Text] [Related]
14. Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine.
Xia Q; Chou MW; Kadlubar FF; Chan PC; Fu PP
Chem Res Toxicol; 2003 Jan; 16(1):66-73. PubMed ID: 12693032
[TBL] [Abstract][Full Text] [Related]
15. Microsomal metabolism of pyrrolizidine alkaloids from Senecio jacobaea. Isolation and quantification of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine and N-oxides by high performance liquid chromatography.
Ramsdell HS; Kedzierski B; Buhler DR
Drug Metab Dispos; 1987; 15(1):32-6. PubMed ID: 2881756
[TBL] [Abstract][Full Text] [Related]
16. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation.
Clarke L; Waxman DJ
Cancer Res; 1989 May; 49(9):2344-50. PubMed ID: 2706622
[TBL] [Abstract][Full Text] [Related]
17. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP
Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839
[TBL] [Abstract][Full Text] [Related]
18. Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids.
Huan JY; Miranda CL; Buhler DR; Cheeke PR
Toxicol Lett; 1998 Oct; 99(2):127-37. PubMed ID: 9817084
[TBL] [Abstract][Full Text] [Related]
19. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hepatic in vitro metabolism of the pyrrolizidine alkaloid senecionine in sheep and cattle.
Duringer JM; Buhler DR; Craig AM
Am J Vet Res; 2004 Nov; 65(11):1563-72. PubMed ID: 15566096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]